Log In
BCIQ
Print this Print this
 

AO-001

  Manage Alerts
Collapse Summary General Information
Company A2A Pharmaceuticals LLC
Description 
Molecular Target Menin-MLL fusion oncogene
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationLeukemia
Indication DetailsTreat mixed lineage leukemia (MLL)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today